Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shihua Wen

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Headache and Pain|October 3, 2018
Early onset of efficacy with erenumab in patients with episodic and chronic migraineTodd Schwedt, Uwe Reuter, Stewart Tepper, et al.
Neurology. Clinical Practice|February 5, 2026
Effect of Erenumab on Patient-Reported Outcomes in Episodic Migraine in Asia, the Middle East, and Latin America: Results From the EMPOwER StudyShuu-Jiun Wang, Artemio A Roxas, Bibiana Saravia, et al.
Cephalalgia : an International Journal of Headache|June 26, 2021
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER studyShuu-Jiun Wang, Artemio A Roxas, Bibiana Saravia, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Headache and Pain|October 3, 2018
Early onset of efficacy with erenumab in patients with episodic and chronic migraineTodd Schwedt, Uwe Reuter, Stewart Tepper, et al.
Neurology. Clinical Practice|February 5, 2026
Effect of Erenumab on Patient-Reported Outcomes in Episodic Migraine in Asia, the Middle East, and Latin America: Results From the EMPOwER StudyShuu-Jiun Wang, Artemio A Roxas, Bibiana Saravia, et al.
Cephalalgia : an International Journal of Headache|June 26, 2021
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER studyShuu-Jiun Wang, Artemio A Roxas, Bibiana Saravia, et al.
Pageof 3